Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study
Open Access
- 18 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 46 (5), 1114-1125
- https://doi.org/10.1093/schbul/sbaa040
Abstract
The objective of this study is to describe the 2-year real-world clinical outcomes after transition to psychosis in patients at clinical high-risk. The study used the clinical electronic health record cohort study including all patients receiving a first index primary diagnosis of nonorganic International Classification of Diseases (ICD)-10 psychotic disorder within the early psychosis pathway in the South London and Maudsley (SLaM) National Health Service (NHS) Trust from 2001 to 2017. Outcomes encompassed: cumulative probability (at 3, 6, 12, and 24 months) of receiving a first (1) treatment with antipsychotic, (2) informal admission, (3) compulsory admission, and (4) treatment with clozapine and (5) numbers of days spent in hospital (at 12 and 24 months) in patients transitioning to psychosis from clinical high-risk services (Outreach and Support in south London; OASIS) compared to other first-episode groups. Analyses included logistic and 0-inflated negative binomial regressions. In the study, 1561 patients were included; those who had initially been managed by OASIS and had subsequently transitioned to a first episode of psychosis (n = 130) were more likely to receive antipsychotic medication (at 3, 6, and 24 months; all P < .023), to be admitted informally (at all timepoints, all P < .004) and on a compulsory basis (at all timepoints, all P < .013), and to have spent more time in hospital (all timepoints, all P < .007) than first-episode patients who were already psychotic when seen by the OASIS service (n = 310), or presented to early intervention services (n = 1121). The likelihood of receiving clozapine was similar across all groups (at 12/24 months, all P < .101). Transition to psychosis from a clinical high-risk state is associated with severe real-world clinical outcomes. Prevention of transition to psychosis should remain a core target of future research. The study protocol was registered on www.researchregistry.com; researchregistry5039).Keywords
Funding Information
- National Institute for Health Research
- South London and Maudsley NHS Foundation Trust
This publication has 56 references indexed in Scilit:
- Outreach and support in South London (OASIS), 2001–2011: Ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosisEuropean Psychiatry, 2013
- Lost in transition: setting the psychosis threshold in prodromal researchActa Psychiatrica Scandinavica, 2012
- Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trialBMJ, 2012
- Incidence of Schizophrenia and Other Psychoses in England, 1950–2009: A Systematic Review and Meta-AnalysesPLOS ONE, 2012
- Crisis resolution/home treatment team workers’ understandings of the concept of crisisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2010
- The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid?Schizophrenia Research, 2010
- The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive dataBMC Psychiatry, 2009
- The Lambeth Early Onset Crisis Assessment Team Study: general practitioner education and access to an early detection team in first-episode psychosisThe British Journal of Psychiatry, 2007
- Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental StatesAustralian & New Zealand Journal of Psychiatry, 2005
- Monitoring and Care of Young People at Incipient Risk of PsychosisSchizophrenia Bulletin, 1996